Author: Paul Govern
Oct. 4, 2018—In a study out this week in Science Translational Medicine, an international team led by researchers at Vanderbilt University Medical Center sheds new light on the cause of pulmonary fibrosis and demonstrates a way to impede the disease in mice.
Sep. 27, 2018—by Paul Govern Each year the Nashville Technology Council inducts a tech industry leader to the NTC Hall of Fame, and this year that honor will go to Vanderbilt University Medical Center’s Kevin Johnson, MD, MS, professor and chair of the Department of Biomedical Informatics and Senior Vice President of Health Information Technology. Johnson will...
Sep. 20, 2018—With the help of a $1.6 million grant from the National Heart, Lung and Blood Institute, Vanderbilt University Medical Center is launching a specialized research training program called Vanderbilt Scholars in HIV and Heart, Lung, Blood and Sleep Research, or V-SCHoLARs.
Jun. 28, 2018—Jun. 28, 2018—In an electronic survey of early career research-track faculty at Vanderbilt University Medical Center, respondents confidentially reported their recent experiences with extra-professional caregiving, including care for sick or injured children, parents, spouses or partners.
Apr. 19, 2018—“State Health Policy: Does Evidence Really Make a Difference” was the title of the spring Research into Policy and Practice Lecture, April 11 in Light Hall. The semi-annual lecture is sponsored by the Department of Health Policy.
Apr. 19, 2018—Much of everyday clinical decision-making is informed by lab tests performed rapidly on automated instrumentation — basic metabolic panels, complete blood counts, all the lab orders for which clinicians expect quick results.
Apr. 2, 2018—Vanderbilt University Medical Center is among an initial 39 health systems supporting a new health records feature on the iPhone.
Mar. 29, 2018—Human tumors appear to have a broken circadian clock, researchers at Vanderbilt University Medical Center report in the journal PeerJ.
Mar. 22, 2018—According to the Centers for Disease Control and Prevention, in 2011 in the United States there were almost half a million Clostridium difficile infections, and one in 11 patients 65 or older with a healthcare-associated C. diff infection died within 30 days of diagnosis.
Mar. 1, 2018—Prospective mothers taking a new class of cholesterol-lowering drugs might incur higher risk of spina bifida in their future children, according to a study published in the journal Drug Safety by researchers at Vanderbilt University Medical Center.